Noxxon Pharma AG, a clinical-stage biotechnology company, has appointed Aram Mangasarian to the newly created post of chief business officer with responsibility for corporate and business development.
Dr Mangasarian was previously a vice president for business development at Novexel, a French anti-infectives company which was recently acquired by AstraZeneca.
Dr Mangasarian received his PhD from the University of California and his MBA from INSEAD.
Copyright 2010 Evernow Publishing Ltd